Clinical Trial Update: Adjuvant HIPEC in High Risk Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant HIPEC for high-risk colon cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• HIPEC (adjuvant), heated intraperitoneal chemotherapy

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Colorectal Neoplasms, Peritoneal Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2021-09-16